In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...
Expert Rev Mol Diagn. 2008;8(6):679-688. At one level, there is optimism that IVD tests will at last receive the recognition of their true worth within healthcare delivery, and enhance patient care ...
DUBLIN--(BUSINESS WIRE)--The "Point of Care Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. Globally, the diagnostic testing business is a ...
Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...
DUBLIN, March 17, 2020 /PRNewswire/ -- The "Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application ...
Infectious diseases afflict millions of people every year. These hard-hitting viruses can rapidly sweep through populations and, in some cases, whole continents in a matter of weeks. Identifying and ...
Hosted on MSN
How one company is disrupting PoC testing
The point-of-care (PoC) market continues to gain traction as it is expected to reach a market valuation of US$77.8 billion by 2028 and growing at a compound annual growth rate of 9.4 per cent. PoC ...
The development of new tests to address new diseases, or those that previously had no useful biomarker, is stimulating IVD growth. It is interesting that many of these new analytes are almost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results